RecruitingNot ApplicableNCT05165927

Comparison of Methods in Post Operative Hip Arthroscopy Rehabilitation


Sponsor

University of Colorado, Denver

Enrollment

120 participants

Start Date

Apr 29, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The investigators plan to investigate the efficacy of blood flow restriction (BFR) therapy in post operative rehabilitation following hip arthroscopy. BFR has shown to be great at helping the recovery process. SAGA is a well-known smart training technology company, and the investigators aim to partner with SAGA to use the BFR cuffs as the intervention method. The BFR cuff will be added to the current SOC for hip scope PT for the intervention group.


Eligibility

Min Age: 18 YearsMax Age: 60 Years

Inclusion Criteria1

  • patients with labral tears, femoroacetabular impingement syndrome, loose bodies, ligamentum teres tears, and related intra-articular pathology to be treated with hip arthroscopy. Patients must also have access to a smartphone device in order to utilize the SAGA BFR application for use. The application is free to use.

Exclusion Criteria10

  • bilateral hip surgeries to be performed within 12 weeks of each other, concomitant Peri-acetabular osteotomy, soft tissue repairs (hamstring, glute repairs), clinically diagnosed hip dysplasia, and the following BFR contraindications:
  • Deep Vein Thrombosis (DVT)
  • Pulmonary Embolism
  • Hemorrhagic/Thrombolytic Stroke
  • Clotting Disorders
  • Hemophilia or taking blood thinners
  • Pregnant or up to 6 months post-partum
  • Untreated Hypertension
  • Untreated Hypotension
  • Rhabdomyolysis or recent traumatic injury

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEBFR

BFR cuffs will be used at home during specified exercises in addition to SOC for post hip scope PT.


Locations(1)

UCHealth Steadman Hawkins Clinic Denver

Englewood, Colorado, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05165927


Related Trials